ACAD
32.59
-0.76
-2.28%
AEMD
0.227
-0.013
-5.417%
APRI
1.87
-0.05
-2.60%
ARNA
4.37
-0.11
-2.46%
ATEC
1.45
+0.04
+2.84%
CNAT
7.12
-0.41
-5.44%
CRXM
0.195
0.00
0.00%
CYTX
1.18
-0.02
-1.67%
DXCM
62.34
+0.36
+0.58%
GNMK
12.98
-0.32
-2.41%
HALO
14.28
+0.28
+2.00%
ILMN
185.64
-1.98
-1.06%
INNV
0.14
-0.04
-21.74%
INO
8.16
-0.17
-2.04%
ISCO
0.058
-0.001
-1.1966%
ISIS
63.67
-1.14
-1.76%
LGND
77.11
+0.88
+1.15%
LPTN
2.47
0.00
0.00%
MBVX
1.87
+0.01
+0.54%
MEIP
1.79
+0.04
+2.29%
MNOV
3.5
-0.09
-2.51%
MRTX
29.32
+0.21
+0.72%
MSTX
0.485
-0.012
-2.513%
NBIX
39.71
-1.82
-4.38%
NUVA
45.99
-0.41
-0.88%
ONCS
0.335
-0.015
-4.286%
ONVO
3.54
+0.17
+5.04%
OREX
7.83
+0.08
+1.03%
OTIC
35.36
-0.27
-0.76%
QDEL
26.98
-0.52
-1.89%
RCPT
164.89
+4.84
+3.02%
RGLS
16.94
-0.32
-1.85%
RMD
71.78
+0.13
+0.18%
SCIE
0.03
0.00
+17.65%
SPHS
0.579
+0.029
+5.2545%
SRNE
11.56
+0.2
+1.76%
TROV
6.81
-0.19
-2.71%
VICL
0.945
+0.045
+4.9889%
VOLC
17.99
0.00
0.00%
ZGNX
1.37
0.00
0.00%
ACAD
32.59
-0.76
-2.28%
AEMD
0.227
-0.013
-5.417%
APRI
1.87
-0.05
-2.60%
ARNA
4.37
-0.11
-2.46%
ATEC
1.45
+0.04
+2.84%
CNAT
7.12
-0.41
-5.44%
CRXM
0.195
0.00
0.00%
CYTX
1.18
-0.02
-1.67%
DXCM
62.34
+0.36
+0.58%
GNMK
12.98
-0.32
-2.41%
HALO
14.28
+0.28
+2.00%
ILMN
185.64
-1.98
-1.06%
INNV
0.14
-0.04
-21.74%
INO
8.16
-0.17
-2.04%
ISCO
0.058
-0.001
-1.1966%
ISIS
63.67
-1.14
-1.76%
LGND
77.11
+0.88
+1.15%
LPTN
2.47
0.00
0.00%
MBVX
1.87
+0.01
+0.54%
MEIP
1.79
+0.04
+2.29%
MNOV
3.5
-0.09
-2.51%
MRTX
29.32
+0.21
+0.72%
MSTX
0.485
-0.012
-2.513%
NBIX
39.71
-1.82
-4.38%
NUVA
45.99
-0.41
-0.88%
ONCS
0.335
-0.015
-4.286%
ONVO
3.54
+0.17
+5.04%
OREX
7.83
+0.08
+1.03%
OTIC
35.36
-0.27
-0.76%
QDEL
26.98
-0.52
-1.89%
RCPT
164.89
+4.84
+3.02%
RGLS
16.94
-0.32
-1.85%
RMD
71.78
+0.13
+0.18%
SCIE
0.03
0.00
+17.65%
SPHS
0.579
+0.029
+5.2545%
SRNE
11.56
+0.2
+1.76%
TROV
6.81
-0.19
-2.71%
VICL
0.945
+0.045
+4.9889%
VOLC
17.99
0.00
0.00%
ZGNX
1.37
0.00
0.00%
Home » Archive by Category

Xconomy

Cidara’s $42M Series B May Bring Fungal Therapy to Patients

February 11, 2015 – 10:55 am

Cidara Therapeutics grabbed $42 million in a Series B funding round Wednesday to continue developing its treatment for fungal infections, a therapy that it expects will hit the first stage of…

[[Click headline to continue reading.]]

Cidara’s $42M Series B May Bring Fungal Therapy to Patients

February 11, 2015 – 10:55 am

Cidara Therapeutics grabbed $42 million in a Series B funding round Wednesday to continue developing its treatment for fungal infections, a therapy that it expects will hit the first stage of…

[[Click headline to continue reading.]]

“21st Century Cures” By Year’s End? Its Backers Want More Ideas

February 9, 2015 – 2:59 pm

If you have an idea to include in the bipartisan initiative known as 21st Century Cures, Fred Upton (R-MI) and Diana DeGette (D-CO) say they are all ears. But speak up quickly: They want to present a…

[[Click headline to continue reading.]]

“21st Century Cures” By Year’s End? Its Backers Want More Ideas

February 9, 2015 – 2:59 pm

If you have an idea to include in the bipartisan initiative known as 21st Century Cures, Fred Upton (R-MI) and Diana DeGette (D-CO) say they are all ears. But speak up quickly: They want to present a…

[[Click headline to continue reading.]]

“21st Century Cures” By Year’s End? Its Backers Want More Ideas

February 9, 2015 – 2:59 pm

If you have an idea to include in the bipartisan initiative known as 21st Century Cures, Fred Upton (R-MI) and Diana DeGette (D-CO) say they are all ears. But speak up quickly: They want to present a…

[[Click headline to continue reading.]]

Metasurvey Says: Fewer Biopharmas Capturing More Venture Dollars

February 9, 2015 – 11:01 am

In biotech, young companies have been raising money from public and private investors alike at an astounding rate. But all the rain isn’t letting a thousand flowers bloom. In other words,…

[[Click headline to continue reading.]]

Metasurvey Says: Fewer Biopharmas Capturing More Venture Dollars

February 9, 2015 – 11:01 am

In biotech, young companies have been raising money from public and private investors alike at an astounding rate. But all the rain isn’t letting a thousand flowers bloom. In other words,…

[[Click headline to continue reading.]]

Metasurvey Says: Fewer Biopharmas Capturing More Venture Dollars

February 9, 2015 – 11:01 am

In biotech, young companies have been raising money from public and private investors alike at an astounding rate. But all the rain isn’t letting a thousand flowers bloom. In other words,…

[[Click headline to continue reading.]]

Resistance Is Futile: Why That’s A Good Thing In Biomedicine

February 9, 2015 – 1:00 am

Fans of Star Trek: The Next Generation are very familiar with the Borg, a society of cybernetic individuals linked together in a collective mindset. The Borg navigate the universe in cube-shaped…

[[Click headline to continue reading.]]

Resistance Is Futile: Why That’s A Good Thing In Biomedicine

February 9, 2015 – 1:00 am

Fans of Star Trek: The Next Generation are very familiar with the Borg, a society of cybernetic individuals linked together in a collective mindset. The Borg navigate the universe in cube-shaped…

[[Click headline to continue reading.]]